1.
|
Phase: Phase III, Phase II Type: Treatment Status: Closed Age: any age Sponsor: Protocol IDs: EORTC-30944
|
|
2.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: HOG-GU93-1, NCI-V94-0424
|
|
3.
|
Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: NCI, Other Protocol IDs: DM95-231, P30CA016672, MDA-DM-95231, NCI-G96-1044, CDR0000065105, NCT00002855
|
|
4.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18-70 Sponsor: NCI Protocol IDs: CWRU-1894, NCI-G97-1360
|
|
5.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: SWOG-S9916, CLB-99808, NCCTG-S9916, NCT00004001, S9916
|
|
6.
|
Phase: Phase III Type: Treatment Status: Closed Age: Over 18 Sponsor: NCI Protocol IDs: RTOG-9902, RTOG-DEV-1020, RTOG-99-02, NCT00004054
|
|
7.
|
Phase: Phase III Type: Treatment Status: Closed Age: Any age Sponsor: NCI, Other Protocol IDs: ID00-156, U10CA045809, P30CA016672, MDA-ID-00156, NCI-3410, CDR0000068897, 3410, NCT00024167
|
|
8.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069186, RTOG-P-0014, RTOG-DEV-1028, ECOG-RTOG-P-0014, CALGB-RTOG-P-0014, SWOG-RTOG-P-0014, NCT00030654
|
|
9.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NPCTG-1000
|
|
10.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NPCTG-1300
|
|
11.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NPCTG-1500
|
|
12.
|
Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NPCTG-900
|
|
13.
|
Phase: Phase III Type: Treatment Status: Closed Age: any age Sponsor: Protocol IDs: EORTC-30865
|
|
14.
|
Phase: Phase III Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: MDA-DM-91059, NCI-T92-0007D, T92-0007
|
|
15.
|
Phase: Phase III Type: Treatment Status: Closed Age: Under 80 Sponsor: Other Protocol IDs: CDR0000270970, FRE-FNCLCC-GETUG-12/0203, EU-20238, NCT00055731
|
|
16.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069088, E1899, SWOG-E1899, CALGB-E1899, ECOG-E1899, NCT00027859
|
|
17.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: UCLA-9411413, NCI-V95-0619
|
|
18.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: adult Sponsor: NCI Protocol IDs: MSKCC-95082, NCI-T96-0049H, T96-0049
|
|
19.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CPMC-IRB-7386, NCI-V96-0888, NCT00002775
|
|
20.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-97025, NCI-G97-1269
|
|
21.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-98032, NCI-G98-1448, NCT00003394
|
|
22.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000067324, P30CA016087, NYU-9712, NCI-G99-1596, NCT00004105
|
|
23.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-01064, MSKCC-01064A, NCI-3634, NCT00025194, 3634
|
|
24.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MDA-DM-98268
|
|
25.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000355825, MDA-ID-00087, NCT00082693
|